Dr. Fiona Okwuchi Azubuike, MD

Dr. Azubuike practices at HCA Florida Aventura Hospital in Aventura, Florida, part of HCA Healthcare.

Dr. Azubuike's NPI, 1922282987, was assigned on December 26, 2007. Dr. Azubuike holds New York license 218933-1.

Dr. Azubuike's primary practice is HCA Florida Aventura Hospital, at 20900 Biscayne Blvd, Aventura, FL 33180 in Miami-Dade County. The practice phone is (305) 682-7000.

Dr. Azubuike's primary practice is HCA Florida Aventura Hospital in Aventura, Florida, part of HCA Healthcare. Dr. Azubuike is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Azubuike to 5 more hospitals, 18 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azubuike practices, 8 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Azubuike's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Azubuike is licensed in New York.

CMS data shows 406 Medicare services from Dr. Azubuike across 4 procedure codes in 2024, for 262 Medicare patients. Medicare paid $40,024 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 262 Medicare patients who saw Dr. Azubuike in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azubuike's median patient age at 25, with 58% women.

In 2024, Dr. Azubuike wrote 272 Medicare Part D claims for 186 patients. 93% of them were for generic drugs. CMS names the drug for 111 of them, across 6 drugs with 11 or more claims each, at $683 in total drug cost. In 2023, CMS named 201 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Azubuike for performance year 2024, reported through an alternative payment model (APM). Dr. Azubuike accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Azubuike from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $61.